...
首页> 外文期刊>Hepatology research: the official journal of the Japan Society of Hepatology >Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunction
【24h】

Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunction

机译:安全性和有效性sofosbuvir和利巴韦林日本2基因型丙型肝炎患者肾脏功能障碍

获取原文
获取原文并翻译 | 示例
           

摘要

AimThe safety and efficacy of sofosbuvir (SOF) and ribavirin (RBV) have not been well clarified in patients with renal dysfunction because clinical trials have not included such patients. We evaluated the safety and efficacy of SOF and RBV for genotype 2 hepatitis C virus (HCV)-infected patients with renal dysfunction.
机译:sofosbuvir AimThe安全性和有效性(SOF)和利巴韦林(各类单体)尚未阐明因为临床患者肾功能障碍试验没有包含这样的病人。的安全性和有效性评估SOF和各类单体2基因型丙型肝炎病毒(HCV)来华患者肾脏功能障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号